Aprea Therapeutics Inc.
APRE | NASDAQ
$0.74
-$0.02 (-2.62%)
At close: Sep 21, 2026, 4:00 PM ET
$0.77
+$0.03 (+4.05%)
Pre-market:
Sep 22, 2026, 4:00 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | 118.11K | 280.57K | 486.39K | 841.01K | 1.28M | 1.5M | 1.31M | 1.28M | 963.8K | 583.23K | 569.16K | 249.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 5.43K | 1.92M | 4.4M | 6.75M | 9.6M | 10.25M | 9.36M | 9.05M | 8.33M | 7.97M | 7.63M | 6.11M | 5.11M | 9.72M | 8.46M | 7.93M | 6.81M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -5.43K | -1.8M | -4.11M | -6.27M | -8.76M | -8.96M | -7.86M | -7.74M | -7.05M | -7.01M | -7.04M | -5.54M | -4.86M | -9.72M | -8.46M | -7.93M | -6.81M | n/a | n/a | n/a | n/a | n/a |
Operating Income | -13.22M | -12.58M | -13.23M | -13.82M | -14.8M | -15.26M | -14.32M | -14.77M | -14.19M | -14M | -15.47M | -14.45M | -15.13M | -109.94M | -113.39M | -118.57M | -123.8M | -35.33M | -37.45M | -43.84M | -46.64M | -51.13M |
Interest Income | 763.04K | 582.14K | 652.09K | 808.05K | 1.01M | 1.21M | 1.29M | 1.32M | 1.3M | 1.25M | 1.22M | 1.16M | 986.84K | 703.11K | 448.67K | 208.91K | 57.79K | 5.3K | 3.33K | 4.74K | 4.74K | 7.42K |
Pretax Income | -12.31M | -11.95M | -12.6M | -13.04M | -13.85M | -14.08M | -12.96M | -13.51M | -12.93M | -12.72M | -14.29M | -13.29M | -14.11M | -109.11M | -112.66M | -117.98M | -123.4M | -35.4M | -37.13M | -44.76M | -47.63M | -53.75M |
Net Income | -12.31M | -11.95M | -12.6M | -13.04M | -13.85M | -14.08M | -12.96M | -13.51M | -12.93M | -12.72M | -14.29M | -13.29M | -14.11M | -109.11M | -112.66M | -117.98M | -123.4M | -35.4M | -37.13M | -44.76M | -47.63M | -53.75M |
Selling & General & Admin | 6.5M | 6.53M | 6.48M | 5.91M | 6.04M | 6.29M | 6.46M | 7.03M | 7.14M | 6.99M | 8.43M | 8.9M | 10.27M | 24.2M | 24.82M | 26.07M | 26.4M | 14.11M | 13.55M | 15.08M | 15.14M | 15.58M |
Research & Development | 6.72M | 6.17M | 7.04M | 8.39M | 9.6M | 10.25M | 9.36M | 9.05M | 8.33M | 7.97M | 7.63M | 6.11M | 5.11M | 85.74M | 88.57M | 92.5M | 97.4M | 21.22M | 23.9M | 28.76M | 31.51M | 35.55M |
Other Expenses | -5.19K | -1.92M | -4.4M | -6.76M | -9.6M | -10.25M | -9.36M | -9.05M | -8.33M | -7.97M | -7.63M | -6.11M | -5.11M | -9.72M | -8.46M | -7.93M | -6.81M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 13.22M | 10.78M | 9.12M | 7.55M | 6.04M | 6.29M | 6.46M | 7.03M | 7.14M | 6.99M | 8.43M | 8.9M | 10.27M | 100.22M | 104.93M | 110.64M | 116.99M | 35.33M | 37.45M | 43.84M | 46.64M | 51.13M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33 | 621 | 1.68K | 1.68K | 10.86K | 10.27K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 13.22M | 12.7M | 13.51M | 14.3M | 15.64M | 16.54M | 15.82M | 16.08M | 15.47M | 14.96M | 16.06M | 15.02M | 15.38M | 109.94M | 113.39M | 118.57M | 123.8M | 35.33M | 37.45M | 43.84M | 46.64M | 51.13M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 53.48M | 7.69M | 7.69M | 6.37M | 6.08M | 5.99M | 5.95M | 5.94M | 5.94M | 4.2M | 3.74M | 3.74M | 3.73M | 3.73M | 3.73M | 1.73M | 1.13M | 1.1M | 1.08M | 1.06M | 1.06M | 1.06M |
Shares Outstanding (Diluted) | 53.48M | 7.69M | 7.69M | 6.37M | 6.08M | 5.99M | 5.95M | 5.94M | 5.94M | 4.2M | 3.74M | 3.74M | 3.73M | 3.73M | 3.73M | 1.73M | 1.13M | 1.1M | 1.08M | 1.06M | 1.06M | 1.06M |
EPS (Basic) | -1.29 | -1.75 | -1.98 | -2.15 | -2.32 | -2.37 | -2.38 | -2.81 | -3.03 | -3.32 | -3.92 | -837.43 | -838.98 | -924.87 | -930.85 | -103.62 | -110.11 | -33.03 | -34.91 | -42.24 | -44.97 | -50.80 |
EPS (Diluted) | -1.29 | -1.75 | -1.98 | -2.15 | -2.32 | -2.37 | -2.38 | -2.81 | -3.03 | -3.32 | -3.92 | -837.43 | -838.98 | -924.87 | -930.85 | -103.62 | -110.11 | -33.03 | -34.91 | -42.24 | -44.97 | -50.80 |
EBITDA | -12.29M | -11.93M | -12.58M | -13.02M | -13.83M | -14.06M | -12.94M | -13.49M | -12.91M | -12.7M | -14.28M | -13.28M | -14.1M | -33.29M | -36.78M | -42.03M | -47.39M | -35.14M | -37.38M | -43.85M | -46.65M | -50.89M |
EBIT | -12.31M | -11.95M | -12.6M | -13.04M | -13.85M | -14.08M | -12.96M | -13.51M | -12.93M | -12.72M | -14.29M | -13.29M | -14.11M | -33.29M | -36.85M | -42.16M | -47.59M | -35.39M | -37.65M | -44.12M | -46.9M | -51.13M |
Depreciation & Amortization | 22.03K | 21.71K | 21.71K | 21.71K | 21.71K | 21.59K | 22.32K | 21.88K | 17.88K | 12.8K | 7.05K | 3.17K | 1.86K | 5.36K | 68.71K | 133.61K | 202.93K | 259.44K | 271.68K | 262.58K | 249.82K | 237.84K |
Add to Watchlist
Select watchlists to add or remove APRE